Efficacy and safety of tamoxifen in patients with MPN
A total of 38 patients (27 males and 11 females) were recruited over 118 weeks. The Trial Scheme for Eligibility and Central Analysis is summarized in Supp. Fig. Patients’ characteristicsThree patients achieved the primary outcome (≥50% reduction at 24w) and met the required number for trial success: one 